Forma Life Sciences, which inherited BioDuro’s California production operations earlier this year, has officially ...

With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play.  | BioDuro, headquartered in ...

1. FDA. FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. FDA News Release. March 3, 2026.

Due to the impact of portfolio rationalization, and considering the challenging business environment, the company expects a ...

BioDuro, a CRDMO, has established a joint venture with Cenra API Solutions, a pharmaceutical chemical manufacturer in Taiwan.

Press Release Paris, 3rd March, 2026 Progress against FOCUS-27 in a deteriorating environment Accelerated transformation to strengthen the operating model Full-year 2025 results €848.2 million net ...

Novo Nordisk invests €432M ($506M) in Athlone, Ireland to boost oral glucagon-like peptide-1 manufacturing capacity for global markets by 2028.

While solely API-focused players currently face increased competition, this transition is expected to strengthen long-term pricing power, improve margins, enhance compliance, and increase customer ...

VISAKHAPATNAM: HRD and IT Minister Nara Lokesh performed the groundbreaking ceremony for a greenfield pharmaceutical ...

Apis Capital Advisors increased its stake in Garrett Motion, a key supplier of turbocharging systems used in combustion and hybrid vehicles. With global auto production still dominated by hybrid and ...

A cost-effective Smart Lock platform and SaaS offering for KoreLock-enabled hardware offers consistent, scalable, and ...